|
Module home
Module introduction
Pre-module test
Module information
About the author
Section 1: Treatment of
antidepressant-induced sexual dysfunction
(1.1) Section 1: Treatment of antidepressant-induced sexual
dysfunction
(1.2) Before you begin
(1.3) A woman who thought she was 'frigid'
(1.4) A woman who thought she was 'frigid' (cont..)
(1.5) A woman who thought she was 'frigid' (cont..)
(1.6) A woman who thought she was 'frigid' (cont..)
(1.7) Reflection
(1.8) Reflection (cont..)
(1.9) Overview of treatment strategies
(1.10) Modification of the current antidepressive treatment
(1.11) Treatment of sexual dysfunction targeting specific
receptors
(1.12) Other treatments
(1.13) Reflection
(1.14) Reflection
(1.15) Pharmacological reversal - target noradrenaline
(1.16) Target: noradrenaline
(1.17) Outlook - interactive diagram
(1.18) Reflection
(1.19) Pharmacological reversal - target serotonin
(1.20) Target: serotonin
(1.21) Reflection
(1.22) Pharmacological reversal - target dopamine
(1.23) Target: dopamine
(1.24) Reflection
(1.25) Pharmacological reversal - other targets
(1.26) Other targets
(1.27) Reflection
(1.28) Pharmacological reversal - target nitric oxide
(NO)
(1.29) Phosphodiesterase5
(PD5)-inhibitors
(1.30) It all starts with nitric oxide…
(1.31) PD5-inhibitors contraindications
(1.32) Yet another story...
(1.33) Section 1: Recap
(1.34) Section 1:
Summary
Section 2: Other treatments for
sexual dysfunction
(2.1) Section 2: Other treatments for sexual dysfunction
(2.2) Reflection
(2.3) Reflection (cont..)
(2.4) Hormone treatments for women
(2.5) Reflection
(2.6) Reflection (cont..)
(2.7) Hormone treatments for women - potential side effects
(2.8) Reflection
(2.9) Reflection (cont..)
(2.10) Hormone treatments for men
(2.11) Outlook
(2.12) Reflection
(2.13) Reflection (cont..)
(2.14) Complementary medicines for sexual dysfunction
(2.15) Reflection
(2.16) Reflection (cont..)
(2.17) Reflection
(2.18) Reflection (cont..)
(2.19) LavigraTM
(2.20) ArginMax
(2.21) ProvestraTM
(2.22) Outlook
(2.23) Section 2: Recap
(2.24) Section 2:
Summary
Section 3: Formal aspects of
prescribing for sexual dysfunction
(3.1) Section 3: Formal aspects of prescribing for sexual
dysfunction
(3.2) Reflection
(3.3) Reflection (cont..)
(3.4) The GMC requirements for prescribing unlicensed
medications
(3.5) The GMC requirements for prescribing a medicine for
use
outside the terms of its license
(3.6) Informed consent
(3.7) Quick recap
(3.8) Quick recap (cont..)
(3.9) Reflection
(3.10) Reflection (cont..)
(3.11) The BNF requirements for prescribing for erectile
dysfunction
(3.12) The severe distress clause
(3.13) Section 3: Recap
(3.14) Section 3:
Summary
Module summary
Conclusions
Module test
Take-home notes
References
Acknowledgements
Send feedback
|